Recruiting

Real-World Effectiveness of Dupilumab in Patients With Prurigo Nodularis: An Observational Study

Sponsor:

Sanofi

Code:

NCT05991323

Conditions

Prurigo Nodularis

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Dupilumab

Study Details

Eligibility Criteria

Study Design

Interventions and Outcome Measures

Central Contacts and Locations

More Information